'Vaccinations Should Not Be Free For Non-residents'

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-12-26 HKT 12:10

Share this story

facebook

  • Officials say they aim to implement a plan to reopen the Hong Kong-mainland border by mid-January. File photo: RTHK

    Officials say they aim to implement a plan to reopen the Hong Kong-mainland border by mid-January. File photo: RTHK

A virologist at the University of Hong Kong, Jin Dong-yan, said on Monday he expects the opening of the border between Hong Kong and the mainland to bring "manageable risks" to the SAR, as he and the head of a pharmacists' group both called on authorities to consider charging non-residents for Covid vaccinations here.

Officials have said they aim to start allowing more people to flow through the Hong Kong-mainland border by the middle of next month.

"There's definitely risk as many big cities in mainland China are going through a tsunami phase, so they for sure have relatively more infected people," Jin said on an RTHK programme.

He pointed out that Hong Kong could see an increase in cases, as well as demand for vaccinations and antiviral drugs, when more people are allowed to cross the border.

"But I think all the risks are manageable and we should have a bit more confidence in ourselves," the professor in precision medicine added.

Jin said he believes infected incoming travellers will mostly have mild cases of Covid-19 and that PCR tests will be able to screen them out.

On the question of surging demand for drugs and vaccines, meanwhile, he had a proposal.

"As there are sufficient vaccines in the world, perhaps if we save up more and treat it as a business, that won't be a loss for us," the virologist said.

Non-residents who are not studying or working in Hong Kong should be charged for vaccinations, he continued.

Meanwhile, the president of The Society of Hospital Pharmacists, William Chui, also called on the government to charge non-residents for vaccinations, warning that free jabs and treatments could prompt too many to cross the border to access medical services here and burden the local system.

"People from mainland China demand for more symptomatic relief medications," he said. "They may go to Hong Kong to get more medications. At the moment they are looking for medications on the mainland but the supply is very limited."

Chui urged local pharmaceutical companies to quickly boost their production now in view of surging demand to come.

"The Hong Kong government should contact the local drug manufacturers to increase the manufacturing of paracetamol and also other symptomatic relief medications which may be in great demand by the people of the mainland and the people of Hong Kong."

RECENT NEWS

Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity

Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more

BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom

BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more

Webinar: When Account Takeover Moves Past Onboarding

Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more

JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson

JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more

Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term

The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more

Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal

Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more